Candida commensalism and virulence: the evolution of phenotypic plasticity.

Candida albicans and related species live as benign commensals in one or more body locations in a majority of healthy individuals. As opportunistic pathogens, they are poised to overgrow cavities and penetrate tissue in response to an alteration in host physiology that presumably compromises the immune functions that normally suppress their growth. There is little evidence of the emergence of successful drug-resistant or hypervirulent strains that predominate in either the commensal or disease states. It appears more likely that all strains possess similar capabilities for rapid adaptation to drug therapy, the immune response and changes in body location and in host physiology. It is suggested that the mechanisms for rapid adaptation lie in the developmental programs of the bud-hypha transition and high frequency phenotypic switching, and in the modulation of the expression of virulence genes in response to environmental cues.

[1]  Gow Na Germ tube growth of Candida albicans. , 1997 .

[2]  D. Soll,et al.  Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women , 1991, Journal of clinical microbiology.

[3]  D. Soll,et al.  Parity among the randomly amplified polymorphic DNA method, multilocus enzyme electrophoresis, and Southern blot hybridization with the moderately repetitive DNA probe Ca3 for fingerprinting Candida albicans , 1997, Journal of clinical microbiology.

[4]  D. Soll,et al.  Ca3 Fingerprinting of Candida albicans Isolates from Human Immunodeficiency Virus-Positive and Healthy Individuals Reveals a New Clade in South Africa , 2002, Journal of Clinical Microbiology.

[5]  D. Soll,et al.  EFG1 Null Mutants of Candida albicansSwitch but Cannot Express the Complete Phenotype of White-Phase Budding Cells , 2000, Journal of bacteriology.

[6]  D. Soll,et al.  Ultrastructure and antigenicity of the unique cell wall pimple of the Candida opaque phenotype , 1990, Journal of bacteriology.

[7]  D. Soll,et al.  High-frequency switching of colony morphology in Candida albicans. , 1985, Science.

[8]  D. Soll,et al.  An increase in switching frequency correlates with an increase in recombination of the ribosomal chromosomes of Candida albicans strain 3153A. , 1994, Microbiology.

[9]  D. Soll High-frequency switching in Candida albicans , 1992, Clinical Microbiology Reviews.

[10]  D. Soll The Ins and Outs of DNA Fingerprinting the Infectious Fungi , 2000, Clinical Microbiology Reviews.

[11]  C. Nombela,et al.  Genetic analysis of Candida albicans morphological mutants. , 1985, Journal of general microbiology.

[12]  D. Soll The regulation of cellular differentiation in the dimorphic yeast Candida albicans , 1986, BioEssays : news and reviews in molecular, cellular and developmental biology.

[13]  A. Brown,et al.  Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans , 1994, Molecular microbiology.

[14]  D. Soll,et al.  Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2 , 1996, Journal of clinical microbiology.

[15]  M. Schaller,et al.  Invasion of Candida albicans correlates with expression of secreted aspartic proteinases during experimental infection of human epidermis. , 2000, The Journal of investigative dermatology.

[16]  L. Samaranayake,et al.  Oral candidosis in the elderly in long term hospital care. , 1991, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[17]  D. Soll,et al.  Functional analysis of the promoter of the phase-specific WH11 gene of Candida albicans , 1995, Molecular and cellular biology.

[18]  M. Raymond,et al.  The Candida albicans CDR3 gene codes for an opaque-phase ABC transporter , 1997, Journal of bacteriology.

[19]  D. Soll,et al.  Phenotypic Switching in Candida glabrata Involves Phase-Specific Regulation of the Metallothionein Gene MT-IIand the Newly Discovered Hemolysin Gene HLP , 2000, Infection and Immunity.

[20]  A. Cassone,et al.  The pH of the Host Niche Controls Gene Expression in and Virulence of Candida albicans , 1998, Infection and Immunity.

[21]  F. Odds Switch of phenotype as an escape mechanism of the intruder , 1997, Mycoses.

[22]  D. Soll,et al.  Frequency, intensity, species, and strains of oral Candida vary as a function of host age , 1996, Journal of clinical microbiology.

[23]  P. Wertz,et al.  Differences in adhesion of Candida albicans 3153A cells exhibiting switch phenotypes to buccal epithelium and stratum corneum , 1994, Infection and immunity.

[24]  P. T. Magee,et al.  Opaque-white phenotype transition: a programmed morphological transition in Candida albicans , 1988, Journal of bacteriology.

[25]  D. Soll,et al.  High-frequency switching in Candida strains isolated from vaginitis patients , 1987, Journal of clinical microbiology.

[26]  J. Ernst,et al.  Control of White-Opaque Phenotypic Switching inCandida albicans by the Efg1p Morphogenetic Regulator , 1999, Infection and Immunity.

[27]  T. C. White,et al.  Three distinct secreted aspartyl proteinases in Candida albicans , 1993, Journal of bacteriology.

[28]  D. Soll,et al.  Switching of Candida albicans during successive episodes of recurrent vaginitis , 1989, Journal of clinical microbiology.

[29]  D. Soll,et al.  Hospital Specificity, Region Specificity, and Fluconazole Resistance of Candida albicans Bloodstream Isolates , 1998, Journal of Clinical Microbiology.

[30]  D. Soll,et al.  Natural Defenses against Candida Colonization Breakdown in the Oral Cavities of the Elderly , 1999, Journal of dental research.

[31]  J. Arnold,et al.  Towards understanding the evolution of the human commensal yeast Candida albicans. , 1999, Microbiology.

[32]  T. C. White,et al.  In Vivo Analysis of Secreted Aspartyl Proteinase Expression in Human Oral Candidiasis , 1999, Infection and Immunity.

[33]  D. Soll,et al.  Unique phenotype of opaque cells in the white-opaque transition of Candida albicans , 1987, Journal of bacteriology.

[34]  D. Soll,et al.  Genetic similarity of Candida albicans strains from vaginitis patients and their partners , 1993, Journal of clinical microbiology.

[35]  D. Soll,et al.  A MADS Box Protein Consensus Binding Site Is Necessary and Sufficient for Activation of the Opaque-Phase-Specific Gene OP4 of Candida albicans , 1998, Journal of bacteriology.

[36]  C Russell,et al.  Natural history of Candida species and yeasts in the oral cavities of infants. , 1973, Archives of oral biology.

[37]  D. Soll,et al.  "White-opaque transition": a second high-frequency switching system in Candida albicans , 1987, Journal of bacteriology.

[38]  D. Soll,et al.  Transcription of the gene for a pepsinogen, PEP1, is regulated by white-opaque switching in Candida albicans , 1992, Molecular and cellular biology.

[39]  D. Soll,et al.  Variation in adhesion and cell surface hydrophobicity in Candida albicans white and opaque phenotypes , 1988, Mycopathologia.

[40]  D. Soll,et al.  Hypha formation in the white-opaque transition of Candida albicans , 1989, Infection and immunity.

[41]  R. Diamond,et al.  Effects of neutrophils and in vitro oxidants on survival and phenotypic switching of Candida albicans WO-1 , 1990, Infection and immunity.

[42]  D. Soll,et al.  Elevated Phenotypic Switching and Drug Resistance ofCandida albicans from Human Immunodeficiency Virus-Positive Individuals prior to First Thrush Episode , 2000, Journal of Clinical Microbiology.

[43]  L. Saiman,et al.  Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3 , 1999, Journal of Clinical Microbiology.

[44]  R. Calderone Fungal Pathogenesis: Principles and Clinical Applications , 2001 .